EIR report Archives - Equitypandit

Marksans Pharma Shares Rally 7% Over US FDA Inspection Report with Zero Observations

Chinmay BohraNovember 3, 2023November 3, 2023

by Chinmay BohraNovember 3, 2023November 3, 2023010427

Shares of Marksans Pharma gained more than 7% in trade on Friday after the company announced that its subsidiary received the Establishment Inspection Report from...

Latest News

Alembic Pharma has received EIR report from USFDA

adminOctober 5, 2016

by adminOctober 5, 20160819

Alembic Pharmaceuticals has got the Establishment Inspection Report from the USFDA for its formulation facility located at Panelav in Gujarat. Alembic Pharmaceuticals has said in...

Latest News

Cadila has received EIR from USFDA for Changodar facility

adminAugust 16, 2016

by adminAugust 16, 201601140

Cadila Healthcare has got the Establishment Inspection Report (EIR) for its Changodar manufacturing plant that is located near Ahmedabad, from the US health regulator after...

Latest News

Strides Shasun has received EIR report from USFDA

adminJune 7, 2016

by adminJune 7, 20160661

An Establishment Inspection Report (EIR) has been received by the drug firm Strides Shasun from the US health regulator on closure of inspection of its...

Latest News

Lupin has got EIR report from USFDA on inspection closure

adminMay 27, 2016

by adminMay 27, 201601134

Lupin, the pharma major has got an establishment inspection report (EIR) from the USFDA on closure of inspection of its Mandideep and Aurangabad facilities. Lupin...

Download Unicorn Signals App

EquityPandit

Tag : EIR report

Marksans Pharma Shares Rally 7% Over US FDA Inspection Report with Zero Observations

Alembic Pharma has received EIR report from USFDA

Cadila has received EIR from USFDA for Changodar facility

Strides Shasun has received EIR report from USFDA

Lupin has got EIR report from USFDA on inspection closure

EquityPandit